26 November 2024 - PANTHERx Rare is pleased to announce that it was selected by BridgeBio for the distribution of Attruby (acoramidis), a high affinity transthyretin stabiliser for twice daily oral administration, approved for the treatment of transthyretin amyloid cardiomyopathy.

PANTHERx Rare is a dual accredited specialty pharmacy focused on rare and orphan disease, distributing several orphan products and providing access and support services to those needing them most.

Read PANTHERx Rare press release